118 related articles for article (PubMed ID: 22305579)
1. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes.
Lin CC; Li CI; Yang SY; Liu CS; Chen CC; Fuh MM; Chen W; Li TC
Am J Med; 2012 Apr; 125(4):416.e9-18. PubMed ID: 22305579
[TBL] [Abstract][Full Text] [Related]
2. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study.
Lin CC; Li CI; Liu CS; Lin WY; Chen CC; Yang SY; Lee CC; Li TC
Endocr Relat Cancer; 2012 Aug; 19(4):473-83. PubMed ID: 22544890
[TBL] [Abstract][Full Text] [Related]
3. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
[TBL] [Abstract][Full Text] [Related]
4. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study.
Muggeo M; Verlato G; Bonora E; Zoppini G; Corbellini M; de Marco R
Circulation; 1997 Sep; 96(6):1750-4. PubMed ID: 9323057
[TBL] [Abstract][Full Text] [Related]
5. Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China.
Xu D; Fang H; Xu W; Yan Y; Liu Y; Yao B
Sci Rep; 2016 Dec; 6():39633. PubMed ID: 28004765
[TBL] [Abstract][Full Text] [Related]
6. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men.
Park YW; Chang Y; Sung KC; Ryu S; Sung E; Kim WS
Diabetes Res Clin Pract; 2006 Sep; 73(3):329-35. PubMed ID: 16600415
[TBL] [Abstract][Full Text] [Related]
7. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study).
Simons LA; Simons J; Friedlander Y; McCallum J
Am J Cardiol; 2008 Oct; 102(7):831-4. PubMed ID: 18805106
[TBL] [Abstract][Full Text] [Related]
9. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study.
Muggeo M; Verlato G; Bonora E; Ciani F; Moghetti P; Eastman R; Crepaldi G; de Marco R
Diabetologia; 1995 Jun; 38(6):672-9. PubMed ID: 7672488
[TBL] [Abstract][Full Text] [Related]
10. Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study.
Zoppini G; Verlato G; Targher G; Bonora E; Trombetta M; Muggeo M
Diabetes Metab Res Rev; 2008; 24(8):624-8. PubMed ID: 18802932
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
[TBL] [Abstract][Full Text] [Related]
12. Fasting plasma glucose levels within the normoglycemic range in childhood as a predictor of prediabetes and type 2 diabetes in adulthood: the Bogalusa Heart Study.
Nguyen QM; Srinivasan SR; Xu JH; Chen W; Berenson GS
Arch Pediatr Adolesc Med; 2010 Feb; 164(2):124-8. PubMed ID: 20124140
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria.
Rodrigo E; Santos L; Piñera C; Quintanar JA; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; Arias M
Transplant Proc; 2011; 43(6):2208-10. PubMed ID: 21839235
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
[TBL] [Abstract][Full Text] [Related]
16. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic importance of abnormal glucose metabolism in chronic heart failure].
Guo JC; Li ZP; Gao W; Guo YH; Mao JM
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1385-8. PubMed ID: 20646626
[TBL] [Abstract][Full Text] [Related]
18. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
19. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
Ndrepepa G; Kastrati A; Braun S; Koch W; Kölling K; Mehilli J; Schömig A
Clin Chim Acta; 2006 Nov; 373(1-2):70-6. PubMed ID: 16814762
[TBL] [Abstract][Full Text] [Related]
20. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
